References
- Benson MD. 2007. A hypothesis regarding complement activation and amniotic fluid embolism. Medical Hypotheses 68:1019–1025.
- Benson MD, Kobayashi H, Silver RK, Oi H, Greenberger PA, Terao T. 2001. Immunologic studies in presumed amniotic fluid embolism. Obstetrics and Gynecology 97:510–514.
- Conde-Agudelo A, Romero R. 2009. Amniotic fluid embolism: an evidence-based review. American Journal of Obstetrics and Gynecology 201:445.e1–13.
- Fineschi V, Riezzo I, Cantatore S, Pomara C, Turillazzi E, Neri M. 2009. Complement C3a expression and tryptase degranulation as promising histopathological tests for diagnosing fatal amniotic fluid embolism. Virchows Archiv 454:283–290.
- Gilbert WM, Danielsen B. 1999. Amniotic fluid embolism: decreased mortality in a population-based study. Obstetrics and Gynecology 93:973–977.
- Hammerschmidt DE, Ogburn PL, Williams JE. 1984. Amniotic fluid activates complement. A role in amniotic fluid embolism syndrome? Journal of Laboratory and Clinical Medicine 104:901–907.
- Harboe T, Benson MD, Oi H, Softeland E, Bjorge L, Guttormsen AB. 2006. Cardiopulmonary distress during obstetrical anaesthesia: attempts to diagnose amniotic fluid embolism in a case series of suspected allergic anaphylaxis. Acta Anaesthesiologica Scandinavica 50:324–330.
- Knight M, Berg C, Brocklehurst P, Kramer M, Lewis G, Oats J et al. 2012. Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. BioMed Central Pregnancy Childbirth 12:7.
- Stafford I, Sheffield J. 2007. Amniotic fluid embolism. Obstetrics and Gynecology Clinics of North America 34:545–553.